Biggest News Aggregation in the World
📰 Imerge Study News

Imerge Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Imerge Study. Real-time updates on events, politics, business and more.

Efficacy of Imetelstat in Achieving Red Blood Cell Transfusion Independence (RBC-TI) across Different Risk Subgroups in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis-Stimulating Agents (ESAs) in IMerge Phase 3 Study

Amer Zeidan, MBBS, MHS, presents data from the IMerge phase 3 study on the efficacy of imetelstat in achieving red blood cell transfusion independence across different risk subgroups in patients with lower-risk myelodysplastic syndromes relapsed/refractory to erythropoiesis-stimulating agents.
San Diego United States Samer Zeidan International Prognostic Scoring System Achieving Red Blood Cell Transfusion Independence Different Risk Subgroups

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science